Outcomes of percutaneous coronary intervention for chronic total occlusions in the elderly: A systematic review and

Chenmin Cui1, Zhichao Sheng2

  • 1Department of Nephrology, Huzhou Hospital of Traditional Chinese Medicine Affiliated Zhejiang University of Traditional Chinese Medicine, Huzhou, China.

Clinical Cardiology
|December 17, 2020
PubMed

Insights

Elderly patients undergoing percutaneous coronary intervention (PCI) for chronic total occlusions (CTO) face higher long-term risks, though successful PCI reduces mortality and major adverse cardiac events (MACE). Success rates for CTO-PCI are lower in this age group.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Geriatric Medicine

Background:

  • Percutaneous coronary intervention (PCI) is a key treatment for chronic total occlusions (CTO).
  • Outcomes in elderly patients (≥75 years) undergoing CTO-PCI require specific evaluation due to potential comorbidities and altered physiological responses.
  • Understanding the safety and efficacy of CTO-PCI in older adults is crucial for optimizing cardiovascular care.

Purpose of the Study:

  • To compare outcomes of CTO-PCI in elderly versus nonelderly patients.
  • To assess the impact of successful CTO-PCI on mortality and major adverse cardiac events (MACE) specifically in the elderly population.

Main Methods:

  • A systematic literature search was conducted across major databases (PubMed, Embase, ScienceDirect, CENTRAL, Google Scholar) up to October 2020.
  • Meta-analysis compared in-hospital and long-term mortality and MACE between elderly and nonelderly patients.
  • The study also analyzed the success rates of CTO-PCI and its impact on outcomes in elderly patients.

Main Results:

  • Elderly patients showed a trend towards higher in-hospital MACE and significantly increased long-term mortality and MACE compared to nonelderly patients.
  • The success rate of CTO-PCI was significantly lower in elderly individuals.
  • Successful CTO-PCI in the elderly was associated with a significant reduction in both long-term mortality and MACE.

Conclusions:

  • Elderly patients undergoing CTO-PCI experience higher long-term mortality and MACE, with lower procedural success rates.
  • Successful CTO-PCI in elderly patients significantly mitigates the risks of long-term mortality and MACE.
  • These findings highlight the importance of careful patient selection and procedural optimization for CTO-PCI in older adults.
Abstract

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
121
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
96
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
130
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
150
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
102
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
134